CT26-hHER2

Export PDF

Strain Information

Cell Line

CT26-Tg(hHER2)Smoc

Cat. NO.

NM-S24A-TM40

Model Description

HER2 gene humanized CT26 cell line

Strain State

Validation of tumorigenic capacity completed

Validation Data

2-1.png

Fig1. HER2 expression on in vitro cultured cells of CT26-hHER2 cell line.

2-2.png

Fig2. In vivo validation of CT26-hHER2 in BALB/c mice

2-3.png

Fig3. HER2 expression in tumors after in vivo growth of CT26-hHER2 in wild type BALB/c mice

Related Strain(s)

hHER2*ex20ins-IRES-Luc-2A-EGFP
Cell Line：

hHER2*ex20ins-IRES-Luc-2A-EGFP

Cat. NO.：NM-YD09
MC38-hHER2/Mmp2-KO/Mmp9-KO
Cell Line：MC38-hHER2/Mmp2-KO/Mmp9-KO
Cat. NO.：NMC-230098
MC38-hHER2
Cell Line：

MC38-hHER2

Cat. NO.：NM-S13-TM48
4T1-hHER2-Luc
Cell Line：

4T1-Tg(hHER2-Luc)Smoc

Cat. NO.：NM-S07-TM04
EMT6-hHER2-Luc
Cell Line：

EMT6-Tg(hHER2-Luc)Smoc

Cat. NO.：NM-S22A-TM02

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more